{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:47:59Z","timestamp":1773215279747,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.urology.2014.02.063","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T18:59:19Z","timestamp":1402945159000},"page":"412-420","source":"Crossref","is-referenced-by-count":21,"title":["Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial"],"prefix":"10.1016","volume":"84","author":[{"given":"Germar-Michael","family":"Pinggera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Frauscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius A.","family":"Paduch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Bolyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Efros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jed","family":"Kaminetsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Da Pozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Esler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.02.063_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib2","first-page":"1228","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib3","first-page":"271","article-title":"Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study","volume":"9","author":"Egerdie","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2014.02.063_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","article-title":"Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial","volume":"61","author":"Oelke","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","article-title":"The mechanism of action of phophodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"63","author":"Giuliano","year":"2013","journal-title":"Eur Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.urology.2014.02.063_bib6","first-page":"659","article-title":"Chronic ischemia increases prostatic smooth muscle contraction in the rabbit","volume":"170","author":"Azadzoi","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1464-410X.2005.05777.x","article-title":"Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction","volume":"96","author":"Berger","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.063_bib8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1464-410X.2006.06400.x","article-title":"Atherosclerosis as a risk factor for benign prostatic hyperplasia","volume":"98","author":"Berger","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.063_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1464-410X.2007.07339.x","article-title":"alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms","volume":"101","author":"Pinggera","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.063_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1464-410X.2008.07587.x","article-title":"Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography","volume":"102","author":"Pinggera","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.063_bib11","first-page":"2746","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2014.02.063_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1097-0045(20010301)46:4<281::AID-PROS1034>3.0.CO;2-A","article-title":"Characteristics of normal prostate vascular anatomy as displayed by power Doppler","volume":"46","author":"Leventis","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2014.02.063_bib13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0301-5629(97)00141-5","article-title":"Preliminary results of power Doppler imaging in benign prostatic hyperplasia","volume":"23","author":"Kojima","year":"1997","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.urology.2014.02.063_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1590\/S1677-55382012000200014","article-title":"Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia","volume":"38","author":"Abdelwahab","year":"2012","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib15","first-page":"881","article-title":"Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia","volume":"188","author":"Zhang","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib16","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s11547-009-0449-8","article-title":"Effect of tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US","volume":"114","author":"Bertolotto","year":"2009","journal-title":"Radiol Med"},{"key":"10.1016\/j.urology.2014.02.063_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11934-011-0189-x","article-title":"Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients\u00a0with benign prostatic hyperplasia","volume":"12","author":"Shinbo","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2014.02.063_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1442-2042.2002.00494.x","article-title":"Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy","volume":"9","author":"Tsuru","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib19","first-page":"171","article-title":"Effect of doxazosin on prostatic resistive index in patients with benign prostatic hyperplasia","volume":"14","author":"Ozden","year":"2009","journal-title":"Firat Tip Dergisi"},{"key":"10.1016\/j.urology.2014.02.063_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000277597","article-title":"Effect of transurethral resection of prostate on prostatic resistive index","volume":"84","author":"Ozden","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2014.02.063_bib21","first-page":"2126","article-title":"Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasounds and systematic random biopsies to detect prostate cancer","volume":"185","author":"Morelli","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.063_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.ijir.3901486","article-title":"Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil","volume":"19","author":"Haaga","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2014.02.063_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40266-012-0010-7","article-title":"Tadalafil: in the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction","volume":"29","author":"Curran","year":"2012","journal-title":"Drugs Aging"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:28:41Z","timestamp":1538562521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429514004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0090429514004397"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.02.063","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}